BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19466217)

  • 21. [Surgical treatment of type 2 diabetes mellitus].
    Carrillo-Esper R; Muciño-Bermejo MJ
    Cir Cir; 2014; 82(2):219-30. PubMed ID: 25312324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Metabolic Improvement After Bariatric Surgery: The First Steps Toward Remission of Type 2 Diabetes.
    Grenier-Larouche T; Carreau AM; Carpentier AC
    Can J Diabetes; 2017 Aug; 41(4):418-425. PubMed ID: 28318939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bariatric surgery for the treatment of type 2 diabetes mellitus].
    Benaiges Boix D; Goday Arno A; Pedro-Botet J
    Med Clin (Barc); 2012 Apr; 138(9):391-6. PubMed ID: 21696780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical approaches for the prevention and treatment of type 2 diabetes mellitus.
    Coffin S; Konduru C; Schwarcz M; Frishman W
    Cardiol Rev; 2009; 17(6):275-9. PubMed ID: 19829176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
    Zhang S; Guo W; Wu J; Gong L; Li Q; Xiao X; Zhang J; Wang Z
    Med Sci Monit; 2017 May; 23():2151-2158. PubMed ID: 28477035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
    Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
    Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bariatric surgery as therapy for diabetes mellitus type 2].
    Jazet IM; Janssen IM; Berends FJ; Pijl H; Romijn JA; Meinders AE
    Ned Tijdschr Geneeskd; 2009 May; 153(19):920-5. PubMed ID: 19489298
    [No Abstract]   [Full Text] [Related]  

  • 29. Bariatric surgery: a cure for diabetes?
    Varela JE
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):396-401. PubMed ID: 21505331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of insulin sensitivity and secretion after bariatric/metabolic surgery.
    Mingrone G; Cummings DE
    Surg Obes Relat Dis; 2016 Jul; 12(6):1199-205. PubMed ID: 27568471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of obesity on diabetes mellitus and the role of bariatric surgery.
    Gill RS; Sharma AM; Gill SS; Birch DW; Karmali S
    Maturitas; 2011 Jun; 69(2):137-40. PubMed ID: 21493021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.
    Chaudhry S; Bernardes M; Harris PE; Maffei A
    Minerva Endocrinol; 2016 Mar; 41(1):43-56. PubMed ID: 26505694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
    Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
    Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic control after metabolic surgery: a Granger causality and graph analysis.
    Previti E; Salinari S; Bertuzzi A; Capristo E; Bornstein S; Mingrone G
    Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E622-E630. PubMed ID: 28698280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic surgery for the treatment of type 2 diabetes in obese individuals.
    Cummings DE; Rubino F
    Diabetologia; 2018 Feb; 61(2):257-264. PubMed ID: 29224190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
    Holst JJ
    Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery for Diabetes: Clinical and Mechanistic Aspects.
    Kapeluto J; Tchernof A; Biertho L
    Can J Diabetes; 2017 Aug; 41(4):392-400. PubMed ID: 28739097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic surgery: an increasing place in the management of diabetes].
    De Flines J; Franck M; Rorive M; De Roover A; Paquot N; Scheen AJ
    Rev Med Suisse; 2012 Aug; 8(351):1621-4, 1626-7. PubMed ID: 22988716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-incretin effect: The other face of Janus in human glucose homeostasis.
    Karras SN; Koufakis T; Mustafa OG; Kotsa K
    Obes Rev; 2019 Nov; 20(11):1597-1607. PubMed ID: 31347774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.